Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Schizophrenia Patients
Intervention: Drug: Lurasidone HCl
Sponsor: Dainippon Sumitomo Pharma America
Completed - verified March 2010
Condition: Male, Healthy Normal Subjects
Intervention: Drug: Lurasidone HCl
Sponsor: Dainippon Sumitomo Pharma America
Completed - verified March 2010
Conditions: Male; Healthy Normal Subjects
Intervention: Drug: [ISOTHIAZOLYL-3-14C]-LURASIDONE
Sponsor: Dainippon Sumitomo Pharma America
Completed - verified March 2010
Condition: Schizophrenia or Schizoaffective Disorder
Intervention: Drug: Lurasidone
Sponsor: Dainippon Sumitomo Pharma America
Completed - verified March 2010
Condition: Schizophrenia
Intervention: Drug: Lurasidone HCl
Sponsor: Dainippon Sumitomo Pharma America
Completed - verified March 2010
Condition: Schizophrenia, Schizoaffective Disorder, or Schizophreniform Disorder
Intervention: Drug: Lurasidone HCl
Sponsor: Dainippon Sumitomo Pharma America
Completed - verified February 2010
Condition: Schizophrenia
Intervention: Drug: Lurasidone HCl
Sponsor: Dainippon Sumitomo Pharma America
Completed - verified February 2010